nach oben

Sports Medicine

Erschienen in:

01.02.2007 | Leading Article

Do Inhaled B2-Agonists have an Ergogenic Potential in Non-Asthmatic Competitive Athletes?

verfasst von: Wilfried Kindermann, Professor

Erschienen in: Sports Medicine | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

The prevalence of asthma is higher in elite athletes than in the general population. The risk of developing asthmatic symptoms is the highest in endurance athletes and swimmers. Astma seems particularly widespread in winter-sport athletes such as cross-country skiers. Asthmatic athletes commonly use inhaled β2-agonists to prevent and treat asthmatic symptoms. However, β2-agonists are prohibited according to the Prohibited List of the World Anti-Doping Agency. An exception can be made only for the substances forrnoterol, salbutamol, sahneterol and terbutaline by inhalation, as long as a therapeutic use exemption has been applied for and granted. In this context, the question arises of whether β2-agonists have ergogenic benefits justifying the prohibition of these substances

In 17 of 19 randomised placebo-controlled trials in non-asthmatic competitive athletes, performance-enhancing effects of the inhaled β2-agonists formoterol, salbutarnol, sahneterol and terbutaline could not be proved. This is particularly true for endurance performance, anaerobic power and strength performance. In three of four studies, even supratherapeutic doses of salbutarnol (800–1200μg) had no ergogenic effect. In contrast to inhaled β2-agonists, oral administration of salbutarnol seems to be able to improve the muscle strength and the endurance performance. There appears to be no justification to prohibit inhaled β2-agonists from the point of view of the ergogenic effects.

World Anti-Doping Agency. The prohibited list [online]. Available from URL: http://www.wada-ama.org [Accessed 2006 Dec 13]

Rundell KW, Jenkinson DM. Exercise-induced bronchospasm in the elite athlete. Sports Med 2002; 32: 583–600PubMedCrossRef

Maiolo C, Fuso L, Todaro A, et al. Prevalence of asthma and atopy in Italian Olympic athletes. Int J Sports Med 2004; 25:139–44PubMedCrossRef

Weiler JM, Layton T, Hunt M. Asthma in United States Olympic athletes who participated in the 1996 Summer Games. J Allergy Clin Immunol 1998; 102: 722–6PubMedCrossRef

Weiler JM, Ryan EJ. Asthma in United States Olympic athletes who participated in the 1998 Olympic Winter Games. J Allergy Clin Immunol 2000; 106: 267–71PubMedCrossRef

Wilber RL, Rundell KW, Szmedra L, et al. Incidence of exercise- induced broncho spasm in Olympic winter sport athletes. Med Sci Sports Exerc 2000; 32: 732–7PubMedCrossRef

Helenius N, Tikkanen HO, Sarna S, et al. Asthma and increased bronchial responsiveness in elite athletes: atopy and sport event as risk factors. J Allergy Clin Immunol 1998; 101:646–52PubMedCrossRef

Langdeau JB, Turcotte H, Thibault G, et al. Comparative prevalence of asthma in different groups of athletes: a survey. Can Respir J 2004; 11: 402–6PubMed

Nystad W, Harris J, Borgen JS. Asthma and wheezing among Norwegian elite athletes. Med Sci Sports Exerc 2000; 32:266–70PubMedCrossRef

10.

Mannix ET, Roberts MA, Dukes HJ, et al. Airways hyper responsiveness in high school athletes. J Asthma 2004; 41:567–74PubMedCrossRef

11.

Rupp NT, Guill MF, Brudno DS. Unrecognized exercise-induced bronchospasm in adolescent athletes. Am J Dis Child 1992; 146: 941–4PubMed

12.

Anderson SD, Fitch K, Perry CP, et al. Responses to bronchial challenge submitted for approval to use inhaled beta 2-agonists before an event at the 2002 Winter OIympics. J Allergy Clin Immunol 2003; 111: 45–50PubMedCrossRef

13.

McKenzie DC, Stewart IB, Fitch KD. The asthmatic athlete, inhaled beta agonists, and performance. Clin J Sport Med 2002; 12: 225–8PubMedCrossRef

14.

Pierson WE, Voy RO. Exercise-induced bronchospasm in the XXIII Summer Olympic Games. N Engl Reg Allergy Proc 1988; 9: 209–13PubMedCrossRef

15.

Drobnic F, Freixa A, Casan P, et al. Assessment of chlorine exposure in swimmers during training. Med Sci Sports Exerc 1996; 28: 271–4PubMedCrossRef

16.

Heir T, Oseid S. Self-reported asthma and exercise-induced asthma symptoms in high-level competitive cross-country skiers. Scand J Med Sci Sports 1994; 4: 128–33CrossRef

17.

Helenius I, Haahtela T. Allergy and asthma in elite Summer sport athletes. J Allergy Clin Immunol 2000; 106: 444–52PubMedCrossRef

18.

Langdeau JB, Boulet LP. Prevalence and mechanisms of development of asthma and airway hyper responsiveness in athletes. Sports Med 2001; 31: 601–16PubMedCrossRef

19.

Larsson K, Ohlsen P, Larsson L, et al. High prevalence of asthma in cross-country skiers. BMJ 1993; 307: 1326–9PubMedCrossRef

20.

Sue-Chu M, Larss on L, Bjermer L. Prevalence of asthma in young cross-country skiers in central Scandinavia: differences between Norway and Sweden. Respir Med 1996; 90: 99–105PubMedCrossRef

21.

Thole RT, Sallis RE, Rubin AL, et al. Exercise-induced bronchospasm prevalence in collegiate cross-country runners. Med Sci Sports Exerc 2001; 33: 1641–6PubMedCrossRef

22.

Tikkanen HO, Helenius I. Asthma in runners [letter]. BMJ 1994; 309: 1087PubMedCrossRef

23.

Mannix EF, Farber MO, Palange P, et al. Exercise-induced asthma in figure skaters. Chest 1996; 109: 312–5PubMedCrossRef

24.

Provost-Craig MA, Arbour KS, Sestili DC, et al. The incidence of exercise-induced bronchospasm in competitive figure skaters. J Asthma 1996; 33: 67–71PubMedCrossRef

25.

Rundell KW, Spiering BA, Evans TM, et al. Baseline lung function, exercise-induced broncho constriction, and asthma like symptoms in elite women ice hockey players. Med Sci Sports Exerc 2004; 36: 405–10PubMedCrossRef

26.

Pierson WE, Covert DS, Koenig JQ, et al. Implications of air pollution effects on athletic performance. Med Sci Sports Exerc 1986; 18: 322–7PubMedCrossRef

27.

Heir T, Aanestad G, Carlsen KH, et al. Respiratory tract infection and bronchial responsiveness in elite athletes and sedentary control subjects. Scand J Med Sci Sports 1995; 5: 94–9PubMedCrossRef

28.

Bernard A, Carbonnelle S, Michel O, et al. Lung hyper permeability and asthma prevalence in school children: unexpected associations with the attendance at indoor chlorinated swimming pools. Occup Environ Med 2003; 60: 385–94PubMedCrossRef

29.

Kelly HW. What is new with the beta2-agonists: issues in the management of asthma. Ann Pharmacother 2005; 39: 931–8PubMedCrossRef

30.

Sears MR, Lotvall J. Past, present and future: beta2-adrenoceptor agonists in asthma management. Respir Med 2005;99: 152–70PubMedCrossRef

31.

Ferrari M, Balestreri F, Baratieri S, et al. Evidence of the rapid protective effect of formoterol dry-powder inhalation against exercise-induced broncho spasm in athletes with asthma. Respiration2000; 67: 510–3PubMedCrossRef

32.

Becker JM, Rogers J, Rossini G, et al. Asthma deaths during sports: report of a 7 -year experience. J Allergy Clin Immunol 2004; 113: 264–7PubMedCrossRef

33.

Abramson MJ, Walters J, Walters EH. Adverse effects of betaagonists: are they clinically relevant? Am J Respir Med 2003; 2: 287–97PubMedCrossRef

34.

Anderson SD, Brannan JD. Long-acting beta 2-adrenoceptor agonists and exercise-induced asthma: lessons to guide us in the future. Paediatr Drugs 2004; 6: 161–75PubMedCrossRef

35.

Salpeter SR, Ormiston JM, Salpeter EE. Meta-analysis: respiratory tolerance to regular beta2-agonist use in patients with asthma. Ann Intern Med 2004; 140: 802–13PubMed

36.

Taylor DR, Drazen JM, Herbison GP, et al. Asthma exacerbations during long term beta agonist use: influence of beta(2)adrenoceptor polymorphism. Thorax 2000; 55: 762–7PubMedCrossRef

37.

Nelson HS. Is there a problem with inhaled long-acting betaadrenergic agonists? J Allergy Clin Immunol 2006; 117: 3–16PubMedCrossRef

38.

Rundell KW, Spiering BA, Baumann JM, et al. Effects of montelukast on airway narrowing from eucapnic voluntaryhyperventilation and cold air exercise. Br J Sports Med 2005;

39.

Steinshamn S, Sandsund M, Sue-Chu M, et al. Effects of montelukast on physical perfonnance and exercise economy inadult asthmatics with exercise-induced bronchoconstriction. Scand J Med Sci Sports 2002; 12: 211–7PubMedCrossRef

40.

Todaro A, Faina M, Alippi B, et al. Nedocromil sodium in the prevention of exercise-induced bronchospasm in athletes withasthma. J Sports Med Phys Fitness 1993; 33: 137–45PubMed

41.

Valero A, Garrido E, Malet A, et al. Exercise-induced asthma prophylaxis in athletes using inhaled nedocromil sodium. AIlergol Immunopathol 1996; 24: 81–6

42.

Helenius I, Lumme A, Ounap J, et al. No effect of montelukast on asthma-like symptoms in elite ice hockey players. Allergy2004; 59: 39–44PubMedCrossRef

43.

Sue-Chu M, Sandsund M, Holand B, et al. Montelukastdoes not affect exercise performance at sub freezing temperature inhighly trained non-asthmatic endurance athletes. Int J Sports Med 2000; 21: 424–8PubMedCrossRef

44.

Anderson SD. Single-dose agents in the prevention of exercise induced asthma: a descriptive review. Treat Respir Med 2004; 3: 365–79PubMedCrossRef

45.

Signorile JF, Kaplan T A, Applegate B, et al. Effects of acute inhalation of the bronchodilator, albuterol, on power output. Med Sci Sports Exerc 1992; 24: 638–42PubMed

46.

Morton AR, Papalia SM, Fitch KD. Changes in anaerobic power and strength performance after inhalation of salbutamol in nonasthmatic athletes. Clin J Sport Med 1993; 3: 14–9CrossRef

47.

Bedi IF, Gong H, Horvath SM. Enhancement of exercise performance with inhaled albuterol. Can J Sport Sci 1988; 13:144–8PubMed

48.

Carlsen KH, Ingjer F, Kirkegaard H, et al. The effect of inhaled salbutamol and salmeterol on lung function and endurance performance in healthy well-trained athletes. Scand J Med Sci Sports 1997; 7: 160–5PubMedCrossRef

49.

Carlsen KH, Hem E, Stensrud T, et al. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performancein healthy well-trained athletes. Respir Med 2001; 95: 571–6PubMedCrossRef

50.

Reck SJ, Lucia A, Storms WW, et al. Effects of acute inhalation of albuterol on submaximal and maximal V02 and blood lactate. Int J Sports Med 1993; 14: 239–43CrossRef

51.

Goubault C, Perault MC, Leleu E, et al. Effects of inhaled salbutamol in exercising non-asthmatic athletes. Thorax 2001;56: 675–9PubMedCrossRef

52.

Heir T, Stemshaug H. Salbutamol and high-intensity treadmill running in nonasthmatic highly conditioned athletes. Scand J Med Sci Sports 1995; 5: 231–6PubMedCrossRef

53.

Larsson K, Gavhed D, Larsson L, et al. Influence of a beta2- agonist on physical performance at low temperature in elite athletes. Med Sci Sports Exerc 1997; 29: 1631–6PubMedCrossRef

54.

Lemmeer JT, Reck SJ, Wallach JM, et al. The effects of albuterol on power output in non-asthmatic athletes. Int J Sports Med 1995; 16: 243–9CrossRef

55.

McDowell SL, Fleck SJ, Storms WW. The effects of salmeterol on power output in nonasthmatic athletes. J Allergy Clin ImmunoI 1997; 99: 443–9CrossRef

56.

McKenzie DC, Rhodes EC, Stirling DR, et al. Salbutamol and treadmill performance in non-atopic athletes. Med Sci Sports Exerc 1983; 15: 520–2PubMed

57.

Meeuwisse WH, McKenzie DC, Hopkins SR, et al. The effect of salbutamol on performance in elite nonasthmatic athletes. Med Sci Sports Exerc 1992; 24: 1161–6PubMed

58.

Morton AR, Papalia SM, Fitch KD. Is salbutamol ergogenic? The effects of salbutamol on physical performance in the high performance nonasthmatic athletes. Clin J Sport Med 1992; 2:173–7CrossRef

59.

Morton AR, Joyce K, Papalia SM, et al. Is salmeterol ergogenic? Clin J Sport Med 1996; 6: 220–5PubMedCrossRef

60.

Norris SR, Petersen SR, Jones RL. The effect of salbutamol on performance in endurance cyclists. Eur J Appl Physiol 1996;73: 364–8CrossRef

61.

Sandsund M, Sue-Chu M, Helgerud J, et al. Effect of cold exposure (-15 degrees C) and salbutamol treatment on physical performance in elite nonasthmatic cross-country skiers. Eur J Appl Physiol 1998; 77: 297–304CrossRef

62.

Sue-Chu M, Sandsund M, Helgerud J, et al. Salmeterol and physical performance at -15 degrees C in highly trained nonasthmatic cross-country skiers. Scand J Med Sci Sports 1999; 9: 48–52PubMedCrossRef

63.

Stewart IE, Labreche JM, McKenzie DC. Acute formoterol administration has no ergogenic effect in nonasthmatic athletes. Med Sci Sports Exerc 2002; 34: 213–7PubMedCrossRef

64.

van Baak MA, de Hon OM, Hartgens F, et al. Inhaled salbutamol and endurance cycling performance in non-asthmatic athletes. Int J Sports Med 2004; 25: 533–8PubMedCrossRef

65.

Caruso JF, Signorile JF, Perry AC, et al. The effects of albuterol and isokinetic exercise on the quadriceps muscle group. Med Sci Sports Exerc 1995; 27: 1471–6PubMed

66.

Collomp K, Candau R, Collomp R, et al. Effects of acute ingestion of salbutamol during submaximal exercise. Int J Sports Med 2000; 21: 480–4PubMedCrossRef

67.

Collomp K, Candau R, Lasne F, et al. Effects of short-term oral salbutamol administration on exercise endurance and metabolism. J Appl Physiol 2000; 89: 430–6PubMed

68.

Collomp K, Le Panse B, Portier H, et al. Effects of acute salbutamol intake during a Wingate test. Int J Sports Med 2005; 26: 513–7PubMedCrossRef

69.

Le Panse B, Collomp K, Portier H, et al. Effects of short-term salbutamol ingestion during a Wingate test. Int J Sports Med 2005; 26: 518–23PubMedCrossRef

70.

Martineau L, Horan MA, Rothwell NJ, et al. Salbutamol, a beta 2-adrenoceptor agonist, increases skeletal mulscle strength in young men. Clin Sci 1992; 83: 615–21PubMed

71.

van Baak MA, Mayer LH, Kempinski RE, et al. Effect of salbutamol on muscle strength and endurance performance in nonasthmatic men. Med Sci Sports Exerc 2000; 32: 1300–6PubMedCrossRef

72.

Strømme SB, Boushel R, Ekblom B, et al. Cardiovascular and respiratory aspects of exercise: endurance training. In: KjaerM, Krogsgaard M, Magnusson M, et al., editors. Textbook of Sports Medicine. Oxford, UK: Blackwell Science, 2003: 11–29

73.

Inbar O, Weiner P, Azgad Y, et al. Specific inspiratory muscle training in well-trained endurance athletes. Med Sci Sports Exerc 2000; 32: 1233–7PubMedCrossRef

74.

Corrigan B, Kazlauskas R. Medication use in athletes selected for doping control at the Sydney OIympics (2000). Clin J SportMed 2003; 13: 33–40

75.

Kindermann W. The problem of doping and current doping list. Dtsch Z Sportrned 2004; 55: 90–5

76.

Warner DC, Schnepf G, Barrett MS, et al. Prevalence, attitudes, and behaviors related to the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in student athletes. J Adolesc Health 2002; 30: 150–3PubMedCrossRef

Titel: Do Inhaled B2-Agonists have an Ergogenic Potential in Non-Asthmatic Competitive Athletes?
verfasst von: Wilfried Kindermann, Professor
Publikationsdatum: 01.02.2007
Verlag: Springer International Publishing
Erschienen in: Sports Medicine / Ausgabe 2/2007
Print ISSN: 0112-1642
Elektronische ISSN: 1179-2035
DOI: https://doi.org/10.2165/00007256-200737020-00001

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Knie-TEP: Kein Vorteil durch antibiotikahaltigen Knochenzement

29.05.2024 Periprothetische Infektionen Nachrichten

Zur Zementierung einer Knie-TEP wird in Deutschland zu über 98% Knochenzement verwendet, der mit einem Antibiotikum beladen ist. Ob er wirklich besser ist als Zement ohne Antibiotikum, kann laut Registerdaten bezweifelt werden.

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Do Inhaled B2-Agonists have an Ergogenic Potential in Non-Asthmatic Competitive Athletes?

Abstract

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Knie-TEP: Kein Vorteil durch antibiotikahaltigen Knochenzement

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

Fehlerkultur in der Medizin – Offenheit zählt!

Mehr Frauen im OP – weniger postoperative Komplikationen

Update Orthopädie und Unfallchirurgie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2007

The Need for Greater Disciplinary Balance

Morphological and Neurological Contributions to Increased Strength

Mouthguards in Sport Activities History, Physical Properties and Injury Prevention Effectiveness

A Multidisciplinary Approach to the Evaluation, Reconstruction and Rehabilitation of the Multi-Ligament Injured Athlete

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Knie-TEP: Kein Vorteil durch antibiotikahaltigen Knochenzement

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

Fehlerkultur in der Medizin – Offenheit zählt!

Mehr Frauen im OP – weniger postoperative Komplikationen

Update Orthopädie und Unfallchirurgie